Samira Sakhia latest transaction was an Uninformative Buy of $14.72K.
What was Samira Sakhia's most profitable transaction?
Samira Sakhia’s most profitable transaction was an Informative Buy of TSE:MRV stock on January 7, 2016. The return on the trade was 53.00%.
What is Samira Sakhia's role in Antibe Therapeutics?
Samira Sakhia's role in Antibe Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.